Establishment and Verification of a Predictive Nomogram for New Vertebral Compression Fracture Occurring after Bone Cement Injection in Middle‐Aged and Elderly Patients with Vertebral Compression Fracture

OBJECTIVE New vertebral compression fracture (NVCF) occurring after bone cement injection in middle-aged and elderly patients with vertebral compression fracture is very common. Preoperative baseline characteristics and surgical treatment parameters have been widely studied as a risk factor, but the importance of the patients' laboratory indicators has not been thoroughly explored. We aimed to explore the relationship between laboratory indicators and NVCF, and attempt to construct a clinical prediction model of NVCF together with other risk factors. METHODS Retrospective analysis was performed for 200 patients who underwent bone cement injection (percutaneous kyphoplasty or vertebroplasty) for vertebral compression fractures between January 2019 and January 2020. We consulted the relevant literature and collated the factors affecting the occurrence of NVCF. Feature selection of patients with NVCF was optimized using the least absolute shrinkage and selection operator regression model, which was used to conduct multivariable logistic regression analysis, to create a predictive model incorporating the selected features. The discrimination, calibration, and clinical feasibility of the predictive model were assessed using the concordance index (C-index), calibration plots, and decision curve analysis. Internal validation was performed using Bootstrap resampling verification. RESULTS Time from injury to surgery exceeding 7 days, low osteocalcin levels, elevated homocysteine levels, osteoporosis, mode of operation (percutaneous vertebroplasty), lack of postoperative anti-osteoporosis treatment, and poor diffusion of bone cement were independent risk factors for NVCF in middle-aged and elderly patients with vertebral compression fracture after bone cement injection. The C-index of the nomogram constructed using these seven factors was 0.895, indicating good discriminatory ability. The calibration plot showed that the model was well calibrated. Bootstrap resampling verification yielded a significant C-index of 0.866. Decision curve analysis demonstrated that the greatest clinical net benefit for predicting NVCF after bone cement injection could be achieved with a threshold of 1%-91%. CONCLUSION This nomogram can effectively predict NVCF incidence after bone cement injection in middle-aged and elderly patients with vertebral compression fracture, thus aiding clinical decision-making and postoperative management, promoting effective postoperative rehabilitation, and improving the quality of life.

[1]  Weiyang Zhong,et al.  Clinical Outcomes of Fracture Haemorrhage Aspiration for Percutaneous Vertebroplasty in Treating Osteoporotic Vertebral Compression Fractures , 2021, Journal of pain research.

[2]  Long‐en Chen,et al.  Establishment and validation of a nomogram and web calculator for the risk of new vertebral compression fractures and cement leakage after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures , 2021, European Spine Journal.

[3]  Qiujiang Li,et al.  Development and validation of a nomogram for predicting the probability of new vertebral compression fractures after vertebral augmentation of osteoporotic vertebral compression fractures , 2021, BMC Musculoskeletal Disorders.

[4]  Fanxiao Liu,et al.  The association of homocysteine, folate, vitamin B12, and vitamin B6 with fracture incidence in older adults: a systematic review and meta-analysis , 2021, Annals of translational medicine.

[5]  Wenge Liu,et al.  Does prophylactic vertebral augmentation reduce the refracture rate in osteoporotic vertebral fracture patients: a meta-analysis , 2021, European Spine Journal.

[6]  L. C. Lau,et al.  Global sagittal alignment of the spine, pelvis, lower limb after vertebral compression fracture and its effect on quality of life , 2021, BMC Musculoskeletal Disorders.

[7]  Ye-Soo Park,et al.  Survival Analysis and Risk Factors of New Vertebral Fracture after Vertebroplasty for Osteoporotic Vertebral Compression Fracture. , 2021, The spine journal : official journal of the North American Spine Society.

[8]  S. Lei,et al.  Causal effects of homocysteine levels on the changes of bone mineral density and risk for bone fracture: A two-sample mendelian randomization study. , 2021, Clinical nutrition.

[9]  K. Lu,et al.  Efficacy of annual zoledronic acid in initial percutaneous kyphoplasty patients with osteoporotic vertebral compression fractures: a 3-year follow-up study , 2021, Osteoporosis International.

[10]  Dazhi Yang,et al.  Advances in Vertebral Augmentation Systems for Osteoporotic Vertebral Compression Fractures , 2020, Pain research & management.

[11]  S. Giannini,et al.  Vitamin K and Osteoporosis , 2020, Nutrients.

[12]  Jing Ye,et al.  An individualized gait pattern prediction model based on the least absolute shrinkage and selection operator regression. , 2020, Journal of biomechanics.

[13]  B. Bouvard,et al.  Osteoporosis in older adults. , 2021, Joint bone spine.

[14]  A. Gasbarrini,et al.  Percutaneous vertebroplasty and balloon kyphoplasty in the treatment of osteoporotic vertebral fractures: a prospective randomized comparison , 2020, European Spine Journal.

[15]  Haosheng Wang,et al.  Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[16]  L. Manchikanti,et al.  Current Concepts in the Management of Vertebral Compression Fractures , 2020, Current Pain and Headache Reports.

[17]  Zhiyong Liu,et al.  Percutaneous kyphoplasty for osteoporotic vertebral compression fractures improves spino-pelvic alignment and global sagittal balance maximally in the thoracolumbar region , 2020, PloS one.

[18]  Kai Zhu,et al.  12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women , 2019, Clinical interventions in aging.

[19]  G. Ning,et al.  Which is the best treatment of osteoporotic vertebral compression fractures: balloon kyphoplasty, percutaneous vertebroplasty, or non-surgical treatment? A Bayesian network meta-analysis , 2019, Osteoporosis International.

[20]  Guodong Wang,et al.  Kinetic of bone turnover markers after osteoporotic vertebral compression fractures in postmenopausal female , 2018, Journal of Orthopaedic Surgery and Research.

[21]  D. Vashishth,et al.  Structural role of osteocalcin and osteopontin in energy dissipation in bone. , 2018, Journal of biomechanics.

[22]  Tzung-Yi Tsai,et al.  Earlier Vertebroplasty for Osteoporotic Thoracolumbar Compression Fracture May Minimize the Subsequent Development of Adjacent Fractures: A Retrospective Study. , 2018, Pain physician.

[23]  M. Saito,et al.  The Effects of Homocysteine on the Skeleton , 2018, Current Osteoporosis Reports.

[24]  Yuehua Wu,et al.  The risk factors of vertebral refracture after kyphoplasty in patients with osteoporotic vertebral compression fractures: a study protocol for a prospective cohort study , 2018, BMC Musculoskeletal Disorders.

[25]  O. Musbahi,et al.  Vertebral compression fractures. , 2018, British journal of hospital medicine.

[26]  R. Reis,et al.  Bone turnover markers for early detection of fracture healing disturbances: A review of the scientific literature. , 2015, Anais da Academia Brasileira de Ciencias.

[27]  G. Collins,et al.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement , 2015, BMC Medicine.

[28]  Shiro Tanaka,et al.  Plasma Level of Homocysteine Associated with Severe Vertebral Fracture in Postmenopausal Women , 2013, Calcified Tissue International.

[29]  A. Boskey,et al.  Dilatational band formation in bone , 2012, Proceedings of the National Academy of Sciences.

[30]  Qiang Zhang,et al.  Homocysteine level and risk of fracture: A meta-analysis and systematic review. , 2012, Bone.

[31]  A. LaCroix,et al.  Homocysteine levels and risk of hip fracture in postmenopausal women. , 2009, The Journal of clinical endocrinology and metabolism.

[32]  C. Roux,et al.  Mild prevalent and incident vertebral fractures are risk factors for new fractures , 2007, Osteoporosis International.

[33]  P. Delmas,et al.  Homocysteine and fracture risk in postmenopausal women: the OFELY study , 2007, Osteoporosis International.

[34]  A. Tosteson,et al.  Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025 , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  O. Johnell,et al.  An estimate of the worldwide prevalence and disability associated with osteoporotic fractures , 2006, Osteoporosis International.

[36]  T. Keaveny,et al.  Effects of Bone Cement Volume and Distribution on Vertebral Stiffness After Vertebroplasty , 2001, Spine.